Publications by authors named "Marek Pruszynski"

Claim this Profile
M
May the target be with you: polysaccharide-coated upconverting nanoparticles for macrophage targeting.
Karolina Zajdel, Volodymyr Lobaz, Martin Ondra, Rafal Konefał, Oliver Moravec

Nanoscale· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lu-Gold Nanohybrids in Radiotherapeutic Approaches Against Cancer.
Mathilde Ponchelle, Marek Pruszyński, Edmond Gravel, Eric Doris

Small Sci· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro and in vivo evaluation of anti-HER2 antibody conjugates labelled with Ac.
Kateřina Ondrák Fialová, Lukáš Ondrák, Martin Vlk, Ján Kozempel, Kateřina Nováková, Marek Pruszynski

EJNMMI Radiopharm Chem· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical Evaluation of 225Ac-Labeled Single-Domain Antibody for the Treatment of HER2pos Cancer.
Magdalena Rodak, Yana Dekempeneer, Maria Wojewódzka, Vicky Caveliers, Peter Covens

Mol Cancer Ther· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fe(III) and Cu(II) Complexes of Chlorogenic Acid: Spectroscopic, Thermal, Anti-/Pro-Oxidant, and Cytotoxic Studies.
Monika Kalinowska, Kamila Gryko, Ewelina Gołębiewska, Grzegorz Świderski, Hanna Lewandowska

Materials (Basel)· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Road to Personalized Myeloma Medicine: Patient-specific Single-domain Antibodies for Anti-idiotypic Radionuclide Therapy.
Janik Puttemans, Benoit Stijlemans, Marleen Keyaerts, Sam Vander Meeren, Wim Renmans, Marek Pruszynski

Mol Cancer Ther· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Production and Supply of α-Particle-Emitting Radionuclides for Targeted α-Therapy.
Valery Radchenko, Alfred Morgenstern, Amir R Jalilian, Caterina F Ramogida, Cathy Cutler

J Nucl Med· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiochemical separation of Ra from U and Th sources for Ra/Pb/Bi generator.
Marek Pruszyński, Rafał Walczak, Magdalena Rodak, Frank Bruchertseifer, Alfred Morgenstern

Appl Radiat Isot· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Crystal Structure, Spectroscopic Characterization, Antioxidant and Cytotoxic Activity of New Mg(II) and Mn(II)/Na(I) Complexes of Isoferulic Acid.
Monika Kalinowska, Ewelina Gołębiewska, Liliana Mazur, Hanna Lewandowska, Marek Pruszyński

Materials (Basel)· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trastuzumab Modified Barium Ferrite Magnetic Nanoparticles Labeled with Radium-223: A New Potential Radiobioconjugate for Alpha Radioimmunotherapy.
Weronika Gawęda, Marek Pruszyński, Edyta Cędrowska, Magdalena Rodak, Agnieszka Majkowska-Pilip

Nanomaterials (Basel)· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and Evaluation of Ra-Labeled and Anti-PSMA Targeted NaA Nanozeolites for Prostate Cancer Therapy-Part I.
Malwina Czerwińska, Giulio Fracasso, Marek Pruszyński, Aleksander Bilewicz, Marcin Kruszewski

Materials (Basel)· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trastuzumab Conjugated Superparamagnetic Iron Oxide Nanoparticles Labeled with Ac as a Perspective Tool for Combined α-Radioimmunotherapy and Magnetic Hyperthermia of HER2-Positive Breast Cancer.
Edyta Cędrowska, Marek Pruszyński, Weronika Gawęda, Michał Żuk, Paweł Krysiński

Molecules· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trastuzumab-Modified Gold Nanoparticles Labeled with At as a Prospective Tool for Local Treatment of HER2-Positive Breast Cancer.
Łucja Dziawer, Agnieszka Majkowska-Pilip, Damian Gaweł, Marlena Godlewska, Marek Pruszyński

Nanomaterials (Basel)· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
d-Amino Acid Peptide Residualizing Agents for Protein Radioiodination: Effect of Aspartate for Glutamate Substitution.
Marek Pruszynski, Choong Mo Kang, Eftychia Koumarianou, Ganesan Vaidyanathan, Michael R Zalutsky

Molecules· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of an Anti-HER2 Nanobody Labeled with Ac for Targeted α-Particle Therapy of Cancer.
Marek Pruszynski, Matthias D'Huyvetter, Frank Bruchertseifer, Alfred Morgenstern, Tony Lahoutte

Mol Pharm· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functionalized TiO nanoparticles labelled with Ac for targeted alpha radionuclide therapy.
Edyta Cędrowska, Marek Pruszynski, Agnieszka Majkowska-Pilip, Sylwia Męczyńska-Wielgosz, Frank Bruchertseifer

J Nanopart Res· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
I-labeled Anti-HER2 Camelid sdAb as a Theranostic Tool in Cancer Treatment.
Matthias D'Huyvetter, Jens De Vos, Catarina Xavier, Marek Pruszynski, Yann G J Sterckx

Clin Cancer Res· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
At labeled substance P (5-11) as potential radiopharmaceutical for glioma treatment.
Monika Lyczko, Marek Pruszynski, Agnieszka Majkowska-Pilip, Krzysztof Lyczko, Bogdan Was

Nucl Med Biol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
N-Succinimidyl 3-((4-(4-[(18)F]fluorobutyl)-1H-1,2,3-triazol-1-yl)methyl)-5-(guanidinomethyl)benzoate ([(18)F]SFBTMGMB): a residualizing label for (18)F-labeling of internalizing biomolecules.
Ganesan Vaidyanathan, Darryl McDougald, Jaeyeon Choi, Marek Pruszynski, Eftychia Koumarianou

Org Biomol Chem· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
N-Succinimidyl guanidinomethyl iodobenzoate protein radiohalogenation agents: influence of isomeric substitution on radiolabeling and target cell residualization.
Jaeyeon Choi, Ganesan Vaidyanathan, Eftychia Koumarianou, Darryl McDougald, Marek Pruszynski

Nucl Med Biol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stability and in vivo behavior of Rh[16aneS4-diol]211 at complex: a potential precursor for astatine radiopharmaceuticals.
Marek Pruszyński, Monika Łyczko, Aleksander Bilewicz, Michael R Zalutsky

Nucl Med Biol· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
D-Amino acid peptide residualizing agents bearing N-hydroxysuccinimido- and maleimido-functional groups and their application for trastuzumab radioiodination.
Marek Pruszynski, Eftychia Koumarianou, Ganesan Vaidyanathan, Satish Chitneni, Michael R Zalutsky

Nucl Med Biol· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiolabeling and in vitro evaluation of (67)Ga-NOTA-modular nanotransporter--a potential Auger electron emitting EGFR-targeted radiotherapeutic.
Eftychia Koumarianou, Tatiana A Slastnikova, Marek Pruszynski, Andrey A Rosenkranz, Ganesan Vaidyanathan

Nucl Med Biol· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adsorption of Cs on titanate nanostructures.
Barbara Filipowicz, Marek Pruszyński, Seweryn Krajewski, Aleksander Bilewicz

J Radioanal Nucl Chem· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved tumor targeting of anti-HER2 nanobody through N-succinimidyl 4-guanidinomethyl-3-iodobenzoate radiolabeling.
Marek Pruszynski, Eftychia Koumarianou, Ganesan Vaidyanathan, Hilde Revets, Nick Devoogdt

J Nucl Med· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis